Azra AI
Claimed
Azra AI
Azra AI develops AI-powered solutions aimed at optimizing clinical workflows in healthcare, particularly in oncology and radiology. Their technology is used to automate the identification and prioritization of cancer patients from pathology reports, manage incidental findings in radiology, and streamline tumor registry processes.
Product Overview
Security and Compliance Certifications: HITRUST CSF, HIPAA
Azra AI develops AI-powered solutions aimed at optimizing clinical workflows in healthcare, particularly in oncology and radiology. Their technology is used to automate the identification and prioritization of cancer patients from pathology reports, manage incidental findings in radiology, and streamline tumor registry processes. By integrating with existing healthcare systems, Azra AI's tools help healthcare providers deliver timely and efficient care, reduce workflow inefficiencies, and ensure compliance with regulatory standards.
Customers Served
Categories
Company Info
HQ Location
Nashville, Tennessee
Founded
2022
Headcount
11-50
Total Funding
Not available
Latest Round
Not available
Latest Round
Not available
Company Socials
Vendor’s Notes
Use Cases
Customers use Azra AI to identify incidental findings, streamline patient navigation, and accelerate time to treatment in oncology care and beyond.
Core Differentiators
Azra AI is the only end-to-end oncology platform, automating care from suspicion to survivorship with customizable workflows and real-time insights.
Demos
Customers
3
Verified customers
0.7
Median usage (years)
Type
0
1
2
3
Hospitals / Health System (3)
Provider Headcount
0
1
2
5001+ (2)
Showcased Customers
See all (3)Azra AI, a healthtech leader harnessing artificial intelligence (AI) and workflow automation to accelerate the identification and treatment of cancer, has partnered with MultiCare Health System to implement its comprehensive oncology platform. MultiCare will utilize Azra AI's end-to-end solution to enhance patient care and operational efficiency across the entire cancer care continuum, from suspicion to survivorship.